Asset Publisher

Research

ACROBAT-Newborns

Appraising the Critical Role of prognostic Biomarkers in the Assessment and Triage of sick African newborns: Advancing a point-of-care device based on sTREM-1 towards CE marking and implementation

Photo: Issouf Sanogo | gettyimages
Duration
01/01/2025 - 31/12/2029
Coordinator
Bàrbara Baro Sastre
Funded by
EDCTP3

In sub-Saharan Africa, newborns face a high risk of severe illness and mortality, yet current methods for assessing infection severity often fall short, leading to misclassification and delayed care. The EU-funded ACROBAT Newborns project addresses this gap with the newly developed B-Triage, a rapid, point-of-care test that measures sTREM-1, a reliable biomarker for sepsis. This device provides a precise, independent prediction of illness severity across a range of conditions, helping prioritise care for the most vulnerable. The project will conduct clinical studies in Ethiopia, Gabon, Mozambique and Uganda, advancing B-Triage’s validation, industrialisation and market introduction in Africa. By improving healthcare resources, this innovation is aimed at improving survival rates and treatment outcomes for newborns.

 

Total Funding

4.808.065€

Our Team

Co-PIs

ISGlobal Team

Other projects

INCENTIVE

Indo-European Consortium for Next Generation Influenza Vaccine Innovation

FLAVOBAC

Nuevas moléculas de oro coordinadas con flavonoides contra bacterias patógenas multirresistentes prioritarias

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

ENDÈMIC

Community knowledge generation through scientific culture, urban ecology and art